Search Results 51-60 of 16424 for Proto-oncogene
The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
... oncogenes frequently affected in lung cancers. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most ...
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the ...
Cancer disparities · Cancer stem cells · Cancer systems biology · Oncogenic gene dysregulation and carcinogenesis · Precision cancer medicine and translational ...
Oncogenic osteomalacia, also referred to as tumor-induced osteomalacia (TIO), is a rare disorder characterized by urinary phosphate wasting due to an ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
... . VID-20441363. Home; New tumor-shrinking nanoparticle to fight cancer, prevent recurrence. Double your impact on cancer!
* Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.